Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device?
DAIC
FEBRUARY 27, 2024
The study will compare the safety and efficacy of the Laminar LAAX System to commercially available left atrial appendage (LAA) closure devices, providing a potential non-pharmacologic alternative for eligible patients. It's exciting to be part of the evolution of the latest technology into a tangible solution for treating patients.
105 
Let's personalize your content